Marvel Biosciences has secured funding from Alberta Innovates, the organizations revealed this week. Calgary-based Marvel is receiving non-dilutive funding through Alberta Innovates’ CarE market access program to support Phase I testing of its lead compound, MB-204. Trading publicly as MRVL on the TSXV, Marvel is a drug discovery company developing novel therapeutics for autism spectrum […]
Calgary.Tech